Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease Azrin N. Abd RahmanSusan E. TettChristine E. Staatz Review Article 09 March 2013 Pages: 303 - 331
Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations Ibrahim InceCatherijne A. J. KnibbeSaskia N. de Wildt Review Article 06 March 2013 Pages: 333 - 345
Single-Center Evaluation of the Single-Dose Pharmacokinetics of the Angiotensin II Receptor Antagonist Azilsartan Medoxomil in Renal Impairment Richard A. PrestonAziz KarimDomenic A. Sica Original Research Article 11 April 2013 Pages: 347 - 358
Quantifying the Effect of Covariates on Concentrations and Effects of Steady-State Phenprocoumon Using a Population Pharmacokinetic/Pharmacodynamic Model Khaled AbduljalilSimone LazarUwe Fuhr Original Research Article 22 March 2013 Pages: 359 - 371
Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function Janna K. DuongShaun S. KumarRichard O. Day Original Research Article 09 March 2013 Pages: 373 - 384
Pharmacokinetics of Intravenous Conivaptan in Subjects With Hepatic or Renal Impairment Michael J. RoyKeith A. ErdmanJames J. Keirns Original Research Article 01 March 2013 Pages: 385 - 395
Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of Fentanyl Donald R. TaylorAllen W. BurtonLuis M. Torres Correspondence 04 April 2013 Pages: 397 - 398